Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Orlistat, a new lipase inhibitor for the management of obesity.
Heck AM, Yanovski JA, Calis KA. Heck AM, et al. Among authors: calis ka. Pharmacotherapy. 2000 Mar;20(3):270-9. doi: 10.1592/phco.20.4.270.34882. Pharmacotherapy. 2000. PMID: 10730683 Free PMC article. Review.
Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions.
McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Hubbard VS, Yanovski JA. McDuffie JR, et al. Among authors: calis ka. Obes Res. 2002 Jul;10(7):642-50. doi: 10.1038/oby.2002.87. Obes Res. 2002. PMID: 12105286 Clinical Trial.
Effects of orlistat on fat-soluble vitamins in obese adolescents.
McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. McDuffie JR, et al. Among authors: calis ka. Pharmacotherapy. 2002 Jul;22(7):814-22. doi: 10.1592/phco.22.11.814.33627. Pharmacotherapy. 2002. PMID: 12126214
Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions.
McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA. McDuffie JR, et al. Among authors: calis ka. J Pediatr Endocrinol Metab. 2004 Mar;17(3):307-19. doi: 10.1515/jpem.2004.17.3.307. J Pediatr Endocrinol Metab. 2004. PMID: 15112907 Free PMC article. Clinical Trial.
Additive gastrointestinal effects with concomitant use of olestra and orlistat.
Heck AM, Calis KA, McDuffie JR, Carobene SE, Yanovski JA. Heck AM, et al. Among authors: calis ka. Ann Pharmacother. 2002 Jun;36(6):1003-5. doi: 10.1345/aph.1A353. Ann Pharmacother. 2002. PMID: 12022901
Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
Estes KE, Penzak SR, Calis KA, Walsh TJ. Estes KE, et al. Among authors: calis ka. Pharmacotherapy. 2009 Jan;29(1):17-30. doi: 10.1592/phco.29.1.17. Pharmacotherapy. 2009. PMID: 19113794 Review.
Symptomatic cardiotoxicity associated with 5-fluorouracil.
Meyer CC, Calis KA, Burke LB, Walawander CA, Grasela TH. Meyer CC, et al. Among authors: calis ka. Pharmacotherapy. 1997 Jul-Aug;17(4):729-36. Pharmacotherapy. 1997. PMID: 9250550 Clinical Trial.
Quality of pharmacotherapy consultations provided by drug information centers in the United States.
Calis KA, Anderson DW, Auth DA, Mays DA, Turcasso NM, Meyer CC, Young LR. Calis KA, et al. Pharmacotherapy. 2000 Jul;20(7):830-6. doi: 10.1592/phco.20.9.830.35193. Pharmacotherapy. 2000. PMID: 10907973
Development of a questionnaire for detecting potential adverse drug reactions.
Corso DM, Pucino F, DeLeo JM, Calis KA, Gallelli JF. Corso DM, et al. Among authors: calis ka. Ann Pharmacother. 1992 Jul-Aug;26(7-8):890-6. doi: 10.1177/106002809202600704. Ann Pharmacother. 1992. PMID: 1504394
Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.
Sam WJ, Roza O, Hon YY, Alfaro RM, Calis KA, Reynolds JC, Yanovski JA. Sam WJ, et al. Among authors: calis ka. J Clin Pharmacol. 2017 Feb;57(2):219-229. doi: 10.1002/jcph.796. Epub 2016 Aug 23. J Clin Pharmacol. 2017. PMID: 27407018 Free PMC article. Clinical Trial.
90 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback